Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | NFIA |
| Upstream (Parents) |
|---|
| (<<) ABCF1 → NFIA |
| (<<) ADORA2B → NFIA |
| (<<) BLNK → NFIA |
| (<<) CASP10 → NFIA |
| (<<) DUSP4 → NFIA |
| (<<) DUSP6 → NFIA |
| (<<) ENO2 → NFIA |
| (<<) FA2H → NFIA |
| (<<) FZD4 → NFIA |
| (<<) KRT16 → NFIA |
| (<<) KRT6B → NFIA |
| (<<) MLPH → NFIA |
| (<<) MMP7 → NFIA |
| (<<) NFKBIZ → NFIA |
| (<<) PRKCH → NFIA |
| (<<) SPDEF → NFIA |
| (<<) TMEM45B → NFIA |
| Downstream (Children) |
|---|
| NFIA → ABLIM1 (>>) |
| NFIA → CACNA1I (>>) |
| NFIA → CPD (>>) |
| NFIA → EGF (>>) |
| NFIA → FERMT1 (>>) |
| NFIA → FZD9 (>>) |
| NFIA → GNG12 (>>) |
| NFIA → IGFBP2 (>>) |
| NFIA → ILDR1 (>>) |
| NFIA → ITGB6 (>>) |
| NFIA → KCNG1 (>>) |
| NFIA → KLK10 (>>) |
| NFIA → KRT5 (>>) |
| NFIA → MMP15 (>>) |
| NFIA → NDRG1 (>>) |
| NFIA → PCSK1N (>>) |
| NFIA → PIK3C2B (>>) |
| NFIA → PIK3R1 (>>) |
| NFIA → PIK3R3 (>>) |
| NFIA → PKIB (>>) |
| NFIA → PPP3CA (>>) |
| NFIA → RGS20 (>>) |
| NFIA → RPS6KA5 (>>) |
| NFIA → S100A2 (>>) |
| NFIA → SLC5A1 (>>) |
| NFIA → SMOX (>>) |
| NFIA → THRB (>>) |
| NFIA → TMCC3 (>>) |
